Jeff Knight
Director de Operaciones en CRINETICS PHARMACEUTICALS, INC. .
Fortuna: 2 M $ al 30/04/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Scott Struthers | M | 62 | 16 años | |
| Wendell Wierenga | M | 76 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 27 años |
| Harry Leonhardt | M | 67 | 4 años | |
| Matthew Fust | M | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 11 años |
| Stephen Betz | M | 58 | 16 años | |
| Kristin Martin | F | 49 | 5 años | |
| Sarah Thailing | F | - | 4 años | |
| Dana Pizzuti | M | 69 | 2 años | |
| Luke Corning | M | 41 | 4 años | |
| Stephanie Okey | F | 64 | 5 años | |
| Bernadette Connaughton | F | 65 | 6 años | |
| Ellen Kullman | F | 68 | 8 años | |
| Marc Wilson | M | 45 | 6 años | |
| Charles Holley | M | 67 | 7 años | |
| Weston Nichols | M | 39 | 6 años | |
| Alan Krasner | M | 60 | 6 años | |
| Jonathan Graham | M | 63 | 9 años | |
| Marcea Lloyd | F | 75 | 5 años | |
| Cynthia Collins | F | 65 | 3 años | |
| Loren Wagner | M | - | 3 años | |
| Lori Johnston | F | 59 | 8 años | |
| Camille Bedrosian | M | 71 | 4 años | |
| Caren Deardorf | F | 59 | 2 años | |
| Rogério Vivaldi Coelho | M | 60 | 2 años | |
| James Hassard | M | 58 | 2 años | |
| Steve Knowles | M | - | 6 años | |
| Jacqueline Pomfret Kirby | F | - | 1 años | |
| Karen Basbaum | F | - | 4 años | |
| Matt McDowell | M | - | - | |
| Brian Russell | M | - | 2 años | |
| Michael Monahan | M | - | 6 años | |
| Garlan Adams | F | - | 3 años | |
| Lisa Portale | F | - | 5 años | |
| Chris Robillard | M | - | 2 años | |
| Adriana Cabré | F | - | 4 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| N. Coles | M | 63 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 años |
| Pamela Wapnick | F | 58 | 9 años | |
| Masaru Matsuda | M | 53 | 3 años | |
| David J. Scott | M | 71 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Madhavan Balachandran | M | 73 | 20 años | |
| Thomas Wiggans | M | 72 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 8 años |
| Danielle Campbell | F | - | 5 años | |
| Thomas Heineman | M | - | 2 años | |
| Sriram Ryali | M | 43 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 años |
| Joseph Newell | M | 54 | 7 años | |
| Robert Azelby | M | 56 | 5 años | |
| Diana McKenzie | F | 59 | 12 años | |
| Catherine Mackey | M | 68 | 2 años | |
| Randal Kirk | M | 70 | 11 años | |
| Magnus Åke Lundberg | M | 68 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 13 años |
| Helen Torley | M | 61 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 años |
| Pablo Cagnoni | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 años |
| William Ringo | M | 78 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 años |
| Paul Goddard | M | 74 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 16 años |
| Fred Hassan | M | 78 | 6 años | |
| Antonio J. Grillo-López | M | 84 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 11 años |
| Vance D. Coffman | M | 79 | 9 años | |
| John E. Osborn | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 años |
| Julianna R. Wood | F | 68 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 10 años |
| Michael Samar | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Jonathan Benjamin | M | - | 3 años | |
| Svetlana Lucas | M | 52 | 1 años | |
| Paul Kassner | M | 58 | 12 años | |
| Peter Heerma | M | 53 | 4 años | |
| Robert Scott | M | 70 | 6 años | |
| Feng Ye | M | 57 | 12 años | |
| Rosh Dias | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 años |
| Mike Ouimette | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 años |
| Lauren Lee | M | - | 2 años | |
| Francesco Galimi | M | 56 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 años |
| Deborah Wenkert | M | 65 | 6 años | |
| Daniel Mikol | M | - | 6 años | |
| Patrick Johnson | M | - | 2 años | |
| Jane Chung | F | 53 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 años |
| Roger Sidhu | M | 48 | 1 años | |
| Goncagul Içören | F | 48 | 4 años | |
| Martina A. Sersch | M | 54 | 2 años | |
| Wen Chen Yeh | M | 61 | 10 años | |
| John Tsai | M | 57 | 1 años | |
| Vanessa Broadhurst | F | 55 | 4 años | |
| Mark Gergen | M | 61 | 1 años | |
| Rolf K. Hoffmann | M | 64 | 12 años | |
| Yujiro Hata | M | 49 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 años |
| James Ferguson | M | 70 | 3 años | |
| Susan R. Lundeen-Smuck | F | 58 | 9 años | |
| Andrew Hamer | M | 62 | 6 años | |
| Corinne Nevinny | F | 64 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 8 años |
| Richard Bryce | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 años |
| Rekha Hemrajani | F | 54 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 años |
| Reshma Kewalramani | M | 51 | 13 años | |
| Warren L. DeSouza | M | 55 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 9 años |
| Robert Goeltz | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 años |
| Caryn McDowell | F | 54 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Anand Varadan | M | 57 | 16 años | |
| Marion McCourt | F | 64 | 3 años | |
| Michael Castagna | M | 47 | 4 años | |
| Nisha Nanda | M | 49 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 años |
| James Scott Whitehurst | M | 58 | 8 años | |
| Stuart Tross | M | 57 | 10 años | |
| Mayank Mamtani | M | - | 2 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 100 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Jeff Knight
- Red Personal